News

Companies are not yet rushing to relocate production to the US, but investment and dealmaking have already slowed ...
Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its ...
Merck (MRK) ended the recent trading session at $80.93, demonstrating a -1.77% change from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.83%. At the same time, ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...
The stock's fall snapped a four-day winning streak.
In Hazle Twp. on the end of a road in Humboldt Industrial Park, Michaels Stores wants to make its distribution center part of ...
Demand fell 1.4 per cent from the previous month in May, the statistics office said on July 4. Read more at straitstimes.com.
Pharmaceutical companies are heading toward a steep patent cliff that could strip more than $230 billion in US drug sales ...
ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...
The S&P 500 added 0.8% on Thursday, July 3, 2025, reaching a record closing high as a strong jobs report helped boost ...
Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...